Assessing the Remedy: The Case for Contracts in Clinical Trials
- 7 April 2011
- journal article
- research article
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 11 (4) , 3-12
Abstract
Current orthodoxy in research ethics assumes that subjects of clinical trials reserve rights to withdraw at any time and without giving any reason. This view sees the right to withdraw as a simple extension of the right to refuse to participate all together. In this paper, however, I suggest that subjects should assume some responsibilities for the internal validity of the trial at consent and that these responsibilities should be captured by contract. This would allow the researcher to impose a penalty on the subject if he were to withdraw without good reason and on a whim. This proposal still leaves open the possibility of withdrawing without penalty when it is in the subject's best interests to do so. Giving researchers recourse to legal remedy may now be necessary to protect the science, as existing methods used to increase retention are inadequate for one reason or another.Keywords
This publication has 46 references indexed in Scilit:
- Ethnic Identity predicts loss-to-follow-up in a health promotion trialContemporary Clinical Trials, 2010
- Recruitment and retention of women for clinical leiomyoma trialsContemporary Clinical Trials, 2010
- Factors associated with non-participation and drop-out in a lifestyle intervention for workers with an elevated risk of cardiovascular diseaseInternational Journal of Behavioral Nutrition and Physical Activity, 2009
- Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysisObesity Reviews, 2009
- Determinants of subject visit participation in a prospective cohort study of HTLV infectionBMC Medical Research Methodology, 2009
- The need to reform our assessment of evidence from clinical trials: A commentaryPhilosophy, Ethics, and Humanities in Medicine, 2008
- Recruitment and retention of low-income minority women in a behavioral intervention to reduce smoking, depression, and intimate partner violence during pregnancyBMC Public Health, 2007
- The Association of Dropout and Outcome in Trials of Antipsychotic Medication and Its Implications for Dealing With Missing DataSchizophrenia Bulletin, 2007
- Contesting the science/ethics distinction in the review of clinical researchJournal of Medical Ethics, 2007
- Type I Error Rates from Mixed Effects Model Repeated Measures Versus Fixed Effects Anova with Missing Values Imputed Via Last Observation Carried ForwardDrug Information Journal, 2001